Advancing Adult Immunization Strategies: A Focus on the Impact of Respiratory Syncytial Virus (RSV) and Cardiorespiratory Outcomes
Funds educational initiatives to improve healthcare professionals’ understanding of RSV’s impact on adult cardiorespiratory health and the importance of immunization strategies.
Funder: Infectious Diseases Society of America
Due Dates: June 30, 2026 (Full application deadline)
Funding Amounts: Up to $200,000 per award; typically single-year projects.
Summary: Supports independent medical education to enhance healthcare professionals’ knowledge of RSV’s impact on adult cardiorespiratory health and immunization strategies.
Key Information: Only organizations (not individuals) in the United States are eligible to apply.
Description
This funding opportunity supports independent medical education initiatives that address critical educational gaps regarding the impact of Respiratory Syncytial Virus (RSV) on adult cardiorespiratory health. Projects should aim to improve healthcare professionals’ understanding of:
- The epidemiology and burden of RSV infection in adults, especially those with cardiovascular disease.
- The link between RSV infection and cardiovascular morbidity and mortality.
- Real-world evidence on RSV prevention and its effects on cardiorespiratory outcomes.
- Current adult RSV vaccination guidelines and recommendations.
- The role of cardiology professionals in identifying, counseling, and managing patients eligible for adult RSV immunization.
- Integrating RSV immunization discussions into cardiovascular disease management.
The grant is intended for organizations, medical societies, and professional schools in the United States, with a focus on projects that can demonstrate measurable improvements in knowledge, competence, or performance among healthcare professionals.
